Skip to main content

HHS, DEA extend telemedicine flexibilities for prescribing controlled meds through 2026

By HHS.gov  
   January 05, 2026

HHS, working with the DEA, on Friday announced a fourth temporary extension of telemedicine flexibilities that allow patients to receive prescriptions for controlled medications without a prior in-person visit. The extension runs through December 31, 2026, preventing disruptions in care while permanent rules are finalized. This action ensures that patients who rely on telemedicine — including seniors, rural residents, people with disabilities, and individuals receiving treatment for mental health conditions or substance use disorder — can continue accessing care without interruption.

Full story


Get the latest on healthcare leadership in your inbox.